|1.||Palanivel, Kandasamy: 3 articles (11/2014 - 09/2013)|
|2.||Kadalmani, Balamuthu: 3 articles (11/2014 - 09/2013)|
|3.||Kanimozhi, Veerasamy: 3 articles (11/2014 - 09/2013)|
|4.||Kim, Bo Yeon: 3 articles (09/2013 - 02/2013)|
|5.||Asami, Yukihiro: 3 articles (09/2013 - 02/2013)|
|6.||Choi, Yung Hyun: 3 articles (09/2013 - 02/2013)|
|7.||Moon, Dong-Oh: 3 articles (09/2013 - 02/2013)|
|8.||Kim, Gi-Young: 3 articles (09/2013 - 02/2013)|
|9.||Ahn, Jong Seog: 3 articles (09/2013 - 02/2013)|
|10.||Akbarsha, Mohammad Abdulkader: 2 articles (11/2014 - 09/2013)|
|1.||Breast Neoplasms (Breast Cancer)
11/01/2014 - "The present study was carried out to elucidate the mechanisms underlying Verrucarin A (VA)-induced cytotoxicity in human breast cancer cell line MDA-MB-231. "
11/01/2014 - "Verrucarin A induces apoptosis through ROS-mediated EGFR/MAPK/Akt signaling pathways in MDA-MB-231 breast cancer cells."
10/01/2014 - "Verrucarin A (VA), an active constituent of pathogenic fungus Myrothecium verrucaria, which has the ability to inhibit the growth of breast cancer cells. "
09/01/2013 - "Verrucarin A, a protein synthesis inhibitor, induces growth inhibition and apoptosis in breast cancer cell lines MDA-MB-231 and T47D."
10/01/2014 - "Verrucarin A alters cell-cycle regulatory proteins and induces apoptosis through reactive oxygen species-dependent p38MAPK activation in the human breast cancer cell line MCF-7."
01/01/2014 - "We found that verrucarin A effectively sensitized cancer cells to treatment with other anti-cancer drugs. "
01/01/2014 - "Moreover, verrucarin A was able to inhibit expression of the SRC-3 target genes MMP2 and MMP13 and attenuated cancer cell migration. "
01/01/2014 - "Verrucarin A was cytotoxic toward multiple types of cancer cells at low nanomolar concentrations, but not toward normal liver cells. "
02/01/2013 - "Therefore, we examined whether verrucarin A (VA) sensitize TRAIL-induced apoptosis in cancer cells by induction of ER stress. "
11/01/1978 - "Increased tumor immunity in mice inoculated with muconomycin A-treated B16 melanoma cells."
10/01/1978 - "Verrucarins A (4) and B (5) and verrucarin A acetate, in vivo antileukemic inactive fungal metabolites, have been oxidized with m-chloroperoxybenzoic acid to give verrucarin beta-9,10-epoxides which show high in vivo activity against P388 mouse leukemia."
09/01/2013 - "Verrucarin A (VA), a protein synthesis inhibitor, derived from the pathogen fungus Myrothecium verrucaria, inhibits growth of leukemia cell lines and activates caspases and apoptosis and inflammatory signaling in macrophages. "
|3.||T-2 Toxin (T 2 Toxin)
|6.||N-Acetylneuraminic Acid (Sialic Acid)
|7.||Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
|8.||Cell Cycle Proteins
|9.||Reactive Oxygen Species (Oxygen Radicals)
|10.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)